NYU Langone Health: Telemedicine “Blueprint” Introduced to Assess/Triage Covid-19 Patients

VERITAS Vision System Is Introduced by Johnson & Johnson

The company will offer live demos of the new system in a wet lab at the Johnson & Johnson booth (#2813) this weekend at the 2021 American Society of Cataract and Refractive Surgery and American Society of Ophthalmic Administrators Annual Meeting.

GenesisCare Orders 27 Elekta Flexitron Treatment Devices

"GenesisCare continues to demonstrate its commitment to improving patient outcomes worldwide and Elekta is delighted to play a vital partnering role to achieve this mission," said Gustaf Salford, Elekta's President and CEO.

FoodMarble AIRE Shown to Exceed the Performance of ‘Gold Standard’ SIBO Testing in Clinical Trial

SIBO is a very common disorder where there are excessive bacteria present in the small intestine. The true prevalence of SIBO in the general population is largely unknown, with some studies estimating its occurrence in up to 15% of healthy individuals. It is also largely associated with many other common clinical conditions, including irritable bowel syndrome, where 40-80% of IBS patients have SIBO.

September 10, 2020

NYU Langone Health: While Covid-19 patients who are unstable and in acute distress may need immediate in-person attention, many patients can be evaluated at home by telemedicine, thereby maintaining social distancing and reducing the spread of the disease. Limited guidance exists, however, for the remote delivery of healthcare, or “healing at a distance,” though the need has risen significantly during the pandemic. Now medical experts affiliated with NYU Long Island School of Medicine and NYU Langone Health have collaborated to develop a template for remote Covid-19 healthcare delivery, including protocols for assessing and triaging patients who may be COVID-positive.

NYU Langone highlights the spectrum of symptoms in persons infected with Covid-19 range from asymptomatic to severe and life-threatening; the more benign manifestations are often able to be managed from home. A new report, titled “A Telemedicine Approach to Covid-19 Assessment and Triage,” published on September 10, 2020, in Medicina, a peer-reviewed scientific and medical journal, outlines protocols for assessing various patient symptoms through virtual means. The paper notes that these protocols are most easily applicable in settings that have adequate internet or phone connections, and that, when the technology is available, telehealth is also promising for the delivery of care to persons living in remote areas where distance is a barrier to seeking help.

“Most physicians have never before practiced telemedicine, and in this new world of a pandemic, our guidelines serve as a blueprint for safe and effective Covid-19 assessments,” said the report’s lead author, Allison B. Reiss, MD, Associate Professor in the Department of Medicine at NYU Long Island School of Medicine and head of the Inflammation Laboratory at NYU Winthrop Hospital’s Research Institute.

A virtual assessment of Covid-19 symptoms is more feasible than one might imagine, according to the report’s authors. A “Decision-tree diagram” in the report helps direct practitioners in classifying the seriousness of the infectious disease, while numerous adaptations to the physical exam can help detect symptoms. The telemedicine physical exam, for example, includes observing the patient’s breathing in order to detect “respiratory distress,” i.e. whether the patient is having trouble breathing, a warning sign of a more serious Covid-19 infection. Dr. Reiss noted that respiratory issues can be discerned virtually by “looking, listening, and counting” a patient’s respiratory rate and respiratory effort. A virtual viewing of the throat could be aided by a flashlight (a household member might assist). A patient exhibiting tenderness to the abdomen, upon their own touch, might indicate telltale COVID-related gastrointestinal issues, and so on.

The report’s guidelines adhere to criteria established by the Centers for Disease Control (CDC), including for assessing the clinical stability of patients.

“The rapid expansion of telemedicine in response to the Covid-19 pandemic allows physicians to safely maintain connections to their patients in a way never before achieved—whether involving COVID-related or other medical issues,” said Eric Goldberg, MD, Senior Medical Director, Department of Medicine at NYU Langone Health and Clinical Associate Professor, NYU Grossman School of Medicine. “Telemedicine can also create deeper connections between a physician and patient, emanating from the personal spaces shared by each.”

The collaborating institutions on the report were actively using telemedicine protocols prior to the onset of the Covid-19 pandemic but saw a rise in daily visits from 50 in early March 2020 to more than 7,000 by April 2020—completing more than 550,000 video visits during the March-August time period. The report authors say that, ultimately, widespread adoption of this technological tool will be determined by formal studies of quality, comparing telehealth versus in-person outcomes.



Our Sister Publication: Biotechnology News Magazine

Subscribe to Medical Device News Magazine here.